Find investors funding Medical companies

Investors funding Medical startups

BAM Ventures

BAM Ventures is a venture capital firm. The firm is based in Los Angeles, California and was founded in 2014. It invests in the commercial, consumer, energy, media, medical and social sectors.


Richard Wolpert

Wolpert is a Co-Founder and serves as the Chief Executive Officer at Hello Tech. He also serves as an Advisor at Jukin Media. Wolpert is also a Venture Advisor at Wonder Ventures. He also serves as Venture Advisor at Zuma Ventures. Wolpert is a Co-Founder and serves as the Chief Executive Officer at Big Monday. He serves as a Venture Partner at Amplify.LA. He also serves as Venture Advisor at Accel. He has been a pioneer in the fields of consumer digital media and entertainment for several years. He is the Founder of Chance Technologies, a technology development and investment portfolio focused on technologically driven entertainment ventures including GameSpy, GameFly, Smilebox, LookOut, Mob.ly, AdECN, Universal Audio, Zetta Systems, Digital Map Products, Intent.com and AudioMill. He served as President of Disney Online from 1996-98, where he was responsible for the business and creative strategy for the company. During his tenure, he oversaw all aspects of Disney Online's internet initiatives, including the Web's most popular family website, Disney.com, as well as the development and successful operation of The Disney Store Online, Disney's prosperous e-commerce business, and Disney's Daily Blast. From 1984-94, he founded and developed several thriving technology companies, including After Hours Software, Bit Jugglers, and Mind Over Technology, among others. Many of these companies have since successfully merged with, or were acquired by, industry giants such as Adobe Systems, Compaq/HP and RealNetworks. Richard began his career at Apple Computer in 1984, where he was involved in the early development of the Macintosh. He has taught classes at both Stanford and UCLA, and he is a Board Member for the Los Angeles Chapter of the Crohn's & Colitis Foundation of America, where he is the Founder of CCFA's camps. He also serves on the board of the UCLA School of Theater Film and Television and on the Board of Governors for Cedars Sinai Medical Center. Richard earned his degree in Math and Computer Science at the University of California, Los Angeles. He also serves as Venture Partner at Amplify.LA. Wolpert is also an Angel Investor.


BioCrossroads

BioCrossroads is a venture capital firm invests in life sciences industry based in Indiana. The firm operates early-stage life sciences venture funds investing in early-stage biotechnology, pharmaceutical, medical device, diagnostic, agtech, biotech and health information technology products and platforms.


Bobby Bahram

Excelerate Health Ventures

Bobby Bahram is a Managing Partner at Excelerate Health Ventures – a seed and early-stage healthcare IT-focused fund. Mr. Bahram has more than 20 years of operational experience building and growing start-up companies and managing high-performing teams. Mr. Bahram’s experience includes serving as a director for a variety of private and public companies and playing an active role in successful spin-offs, mergers and acquisitions. His expertise encompasses development and implementation of strategies for sustainable growth for companies operating in the software, hardware, and services environment as well as navigation of complex financial, organizational, and legal issues. Mr. Bahram has held executive-level positions with a variety of technology-based start-up ventures. He was the founding CEO and served as the CFO and COO of RadarFind, a software and services company that tracked medical equipment and patients in hospitals and was acquired by TeleTracking Technologies. Mr. Bahram is a frequent speaker on entrepreneurial topics. He received an MBA from North Carolina State University with concentration in Technology Commercialization and Finance, and he holds a BS in Electrical Engineering from Clemson University.


Catapult Ventures

Catapult Ventures is a venture capital firm based in Leicester, United Kingdom. The firm was founded in 1999 and invests in the healthcare, medical devices, environment, luxury consumer brands, manufacturing and software sectors.


Columbia Ventures

Columbia Ventures is a private equity firm which also specializes in the venture capital investments. The firm invests in the biomedical, augmented reality, telecommunications, SaaS, manufacturing and real estate development sectors. It was founded in 1989 and is based in Vancouver, Washington.


Eyal Gura

Eyal Gura is the Co-Founder and Chairman of Zebra Medical Vision, a next-generation medical imaging deep learning platform that will enable scalable diagnosis for the 1 billion people to join the middle class by 2020. Eyal is an Angel investor and venture capitalist with Pitango Venture Capital, the largest venture capital fund in the Middle East. Formerly, Co-Founder: PicScout (acquired by Getty Images); PicApp (acquired by Ybrant Digital); The Gifts Project (acquired by eBay). Adviser, WebTeb.com, the leading Arabic medical portal. Member, Advisory Board, Tmura.org. Member of the Board, Latet. Founding Member, Tovanotb.org. Eyal is a faculty member at IDC's Zell entrepreneurship program and a graduate of the Wharton Business School of the University of Pennsylvania. In 2014 Eyal was named a Young Global Leader by the World Economic Forum. Prior to earning his MBA from the Wharton Business school, Eyal graduated his BA with the Zell Entrepreneurship Program of IDC Herzliya, where he also Co-Founded the IEC (first entrepreneurship club in Israel) and now lectures about entrepreneurship and customer development. Gura served in the Israeli Navy Submarine Flotilla in various command positions and despite his workaholic habits, he enjoys scuba-diving , aikido and is a keen karaoke singer.


Bobby Bahram

Excelerate Health Ventures

Bobby Bahram is a Managing Partner at Excelerate Health Ventures – a seed and early-stage healthcare IT-focused fund. Mr. Bahram has more than 20 years of operational experience building and growing start-up companies and managing high-performing teams. Mr. Bahram’s experience includes serving as a director for a variety of private and public companies and playing an active role in successful spin-offs, mergers and acquisitions. His expertise encompasses development and implementation of strategies for sustainable growth for companies operating in the software, hardware, and services environment as well as navigation of complex financial, organizational, and legal issues. Mr. Bahram has held executive-level positions with a variety of technology-based start-up ventures. He was the founding CEO and served as the CFO and COO of RadarFind, a software and services company that tracked medical equipment and patients in hospitals and was acquired by TeleTracking Technologies. Mr. Bahram is a frequent speaker on entrepreneurial topics. He received an MBA from North Carolina State University with concentration in Technology Commercialization and Finance, and he holds a BS in Electrical Engineering from Clemson University.


Delta Partners

Delta Partners is a venture capital firm that invests in early-stage technology and medical companies based in Ireland and the United Kingdom. The firm was founded in 1994 and is based in Dublin, Ireland.


Bobby Yazdani

Signatures Capital

Bobby Yazdani works full-time on the development and support of entrepreneurs through his venture capital firm, Signatures Capital. Drawing from nearly three decades of entrepreneurial experience in Silicon Valley, he mentors, advances and empowers entrepreneurs on their journey to build great companies. In 2014, Bobby was ranked #1 out of 2000 angel investors in a report by CB Insights as having the most successful track record for investing in companies that received follow-on funding. Bobby made his first angel investment in 1989 in medical technology company Masimo (NASDAQ: MASI), where, in addition to providing capital, he wrote software to enhance the accuracy of the company’s early neonatal pulse oximeters. In 1997 Bobby founded Saba, taking the company public in 2000. Today, Saba is the leading provider of Human Capital Development & Management Solutions. Its applications are being used by over 30 million people from 2200 customers across 195 countries and in 37 languages worldwide. While at Saba, he was named a finalist for Ernst & Young Entrepreneur of the Year Award. Saba also earned spots on InformationWeek’s Innovation 100 list and Computerworld’s 100 Emerging Companies to Watch. Prior to Saba, Bobby worked at Oracle in various R&D roles (‘88 –‘97). Bobby has successfully mentored entrepreneurs and invested in over 100 early-stage startups including Aardvark (acq. by Google), Addepar, Atheer Labs, Baarzo (acq. by Google), BaseHealth, Bina Technologies (acq. by Roche), Bonobos, Canary, Clearspring, CleverSense (acq. by Google), Dropbox, FundersClub, Google (NASDAQ: GOOG), GuardantHealth, HomeJoy, inDinero, InstaEdu (acq. by Chegg), KeyChain Logistics, KissMetrics, Klout (acq. by Lithium Technologies), Masimo (NASDAQ: MASI), Medialets, NextBio (acq. by Illumina), Salesforce.com (NYSE: CRM), OpenGov, PassBan (acq. by EMC/RSA), Qwiki (acq. by Yahoo), SoundHound, SweetGreen, ThinkBig Analytics (acq. by Teradata), Uber, Wash.io, Webs.com (acq. by VistaPrint), ZenPayroll and more.Born in Tehran, Iran, Bobby completed high school in England and received a B.A. in Applied Mathematics at the University of California at Berkeley.


Owen Tripp

Owen Tripp is a Co-Founder and serves as the Board Member and Chief Executive Officer at Grand Rounds. He is also an angel investor. He believes that patients will achieve better healthcare outcomes through the intersection of technology, medical expertise and extraordinary patient care. Prior to Grand Rounds, Owen co-founded Reputation.com and served as its Chief Operating Officer. He holds a BA with honors from Trinity College and received an MBA from Stanford Graduate School of Business. He was recently named an "Innovator" in the Institute for Healthcare Consumerism's 2013 Superstar Awards.


Daniel Cane

Modernizing Medicine

Daniel is President and CEO of South Florida based Modernizing Medicine, Inc. – a healthcare company that is revolutionizing the way in which medical information is created, consumed, and utilized to increase efficiency, lower costs, and improve outcomes. Founded in 2010 Modernizing Medicine has grown to over 100 employees and has raised over $19.1M in funding. It was named “Best Startup” at the South Florida Business Journal’s 2011 Entrepreneur Awards. In 2012, Modernizing Medicine was the “Business of the Year” and was the #1 Fastest Growing Company in South Florida’s “Fast 50.” In 2013 Modernizing Medicine was listed at No. 47 on FORBES annual ranking of America’s Most Promising Companies. In its first two years of sales, Modernizing Medicine has closed more the $20M in business and powers more than 14% of the Dermatology market in the US. Daniel has a BS from Cornell University where, as an undergraduate, he co-founded Blackboard Inc. He was instrumental in growing the company through five private rounds of financing - raising over $100M in venture capital and in 2004 helped take the company public on the NASDAQ (BBBB). In 2011, Blackboard was sold for $1.6B. Active in the local community, Daniel serves as the vice-Chairman of the Board at the South Florida Science Museum and is a member of the Foundation Board at Florida Atlantic University. He is an active member of the Business Development Board of Palm Beach County, the Boca Chamber of Commerce, and several local advisory boards. Today, Daniel works, lives and enjoys life with his wife and three children in sunny South Florida.


Whitecap Venture Partners

Whitecap Venture Partners is an early stage venture capital firm that seeks to invest across three industry verticals: food technology, medical technology, and information and communications technologies. The firm operates as the venture capital arm of Whitecastle Investments. It was established in 1989 and is based in Toronto, Ontario.


Arnd Kaltofen-Ehmann

VI Partners AG

Arnd joined VI Partners in August 2001 as a partner focusing on early-stage life science investments. Before that he built a team dedicated to venture capital transactions in the life science and health care industry for KPMG Corporate Finance (98-01). He gained his entrepreneurial experience in several medical device and e-health start-ups where he held various management positions (91-98). As an MD he started his professional career in a university hospital and in medical research (87-91). In addition to being an MD Arnd also holds an MBA from Kellogg Graduate Business School, USA, and WHU Koblenz, Germany, as well as a Postgraduate Degree in Computer Sciences from TU Munich, Germany. He is fluent in German, English and French.


Bruce Robertson

As a Managing Director at H.I.G. BioVentures, Bruce focuses on investment opportunities in the life sciences sector, including biopharmaceuticals, medical devices, and diagnostics. Bruce currently serves on the boards of Apollo Endosurgery, CardioFocus, Cerephex, and Clarus Therapeutics. Bruce has been active in the life sciences sector for more than 20 years. Prior to joining H.I.G., Bruce served most recently as Managing Director at Toucan Capital, an early-stage venture capital fund focusing on life science investments. While at Toucan, Bruce invested in leading drug and device companies throughout the U.S. Prior to Toucan, Bruce was a General Partner at GIV Venture Partners, a venture capital firm focused on early stage investments in the US, India, and China. Prior to his venture capital career, Bruce was Director of Business Development at IGEN International, where he was responsible for formulating and implementing IGEN's partnering and M&A strategies. Bruce started his career as a Research Manager at W.R. Grace & Co., focusing on medical devices. Bruce is on the boards of the Mid-Atlantic Venture Association, Adventist Healthcare, the University of Delaware Research Foundation, and the BioLife Fund of Virginia’s Center for Innovative Technology. Bruce holds a BSE in Chemical Engineering and BA in Mathematics from the University of Pennsylvania, a PhD in Chemical/Biomedical Engineering from the University of Delaware, and an MBA with High Distinction from Harvard Business School.



Sign up to view more

Locations of active Medical investors

Loading...
Find other angel investors and VC's